Table 2. Baseline patient and statin characteristics of cohort (N = 138731).

	# missing	Statin adherent (14328)	Statin non-adherent (124403)	p-value	CVD event	CVD event-free	p-value
Age, years	0	54	49	<1e-20	54	51	<1e-20
Female	15	0.43 (6093)	0.43 (53135)	0.677	.41 (413)	.42 (44174)	.216
Black	0	0.08 (1141)	0.08 (9847)	0.84	.09 (93)	.08 (8099)	.111
Tobacco	0	0.05 (736)	0.04 (5418)	1.69E-05	.1 (102)	.05 (4766)	2.22e-16
Follow up (days)	0	1325	1260	<1e-20	1270	1399	<1e-20
Strength (mg)	8693	46	44	0.000923	66	48	1.44e-14
Days Supply	0	69	67	2.23E-17	64	66	.00143
Number of labs	0	3.8	3.5	0.00018	2.5	3.9	9.48e-9
Number of concomittant drugs	0	5.0	3.8	<1e-20	4.6	4.6	2.78e-5
Number of codes	0	1.7	0.9	<1e-20	.08	1.1	8.89e-6